Evidence map›Paper›PMID 41133011›Full record

ArticleTranslational lung cancer research2025

Early checkpoint inhibition before chemoradiation: is the strategy ready for stage III non-small cell lung cancer?

Nazmul Hasan, Jeremy P Harris, Misako Nagasaka

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Nazmul HasanDivision of Hematology-Oncology, Department of Medicine, University of California, Irvine School of Medicine, Orange, CA, USA.
Jeremy P HarrisDepartment of Radiation Oncology, Chao Family Comprehensive Cancer Center, Orange, CA, USA.
Misako NagasakaDivision of Hematology-Oncology, Department of Medicine, University of California, Irvine School of Medicine, Orange, CA, USA.ORCID https://orcid.org/0000-0001-5308-615X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemoradiationinduction immunotherapy (IIT)locally advancedNon-small cell lung cancer (NSCLC)stage III

Identifiers

PMID41133011
PMCPMC12541875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.